HOME | Career | Contact us | Safety Reporting
COMPOSITION: Each film coated tablet contains Azilsartan kamedoxomil equivalent to Azilsartan medoxomil 40 mg, Chlorthalidone 12.5mg.

INDICATIONS: For the treatment of mild to moderate hypertension.

ADVERSE REACTIONS: Dizziness, diarrhoea, blood creatine phosphokinase increased, hypokalaemia, hyperuricaemia, rise in blood lipids, hyponatraemia, hypomagnesaemia, hyperglycaemia, urticaria and other forms of skin rash, postural hypotension, loss of appetite, minor gastrointestinal distress, and impotence.

CONTRA-INDICATIONS: Patients with anuria, coadministeration of aliskiren-containing products with Arbozil CT in patients with diabetes, pregnancy.

PRECAUTIONS: Correct volume prior to administration of Arbozil CT in patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients, consider withholding or discontinuing the drug if progressive renal impairment becomes evident, If oliguria or hypotension occurs, support blood pressure and renal function; exchange transfusions or dialysis may be required in neonates with a history of in utero exposure to Arbozil CT.

DOSAGE AND ADMINISTRATION: 1 tablet once daily. The dosage may be increased to 40/25 mg after 2 to 4 weeks as needed to achieve blood pressure goals. It may be taken with or without food. 
(Fordetailed information please write to Zuventus Healthcare Limited, 5119, 5thfloor, D-Wing, Oberoi Garden Estates, Chandivali, Andheri (E), Mumbai 400 072or email to medico@zuventus.com)


© 2013. All Rights Reserved. Zuventus HealthCare Ltd.